Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMPD1 | P17405 | 7/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | GGPS1 | O95749 | 6/20 | 0.41 |
| ▸ | FDPS | P14324 | 10/20 | 0.41 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.39 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9659799 | 1.00 | SMPD1 (0.51) | SMPD1CYP3A4L3MBTL1GGPS1FDPS | |
| SCHEMBL27957096 | 1.00 | SMPD1 (0.51) | SMPD1CYP3A4L3MBTL1GGPS1FDPS | |
| SCHEMBL9659289 | 1.00 | SMPD1 (0.51) | SMPD1CYP3A4L3MBTL1GGPS1FDPS | |
| SCHEMBL9660232 | 1.00 | SMPD1 (0.51) | SMPD1CYP3A4L3MBTL1GGPS1FDPS | |
| SCHEMBL7591041 | 1.00 | SMPD1 (0.51) | SMPD1CYP3A4L3MBTL1GGPS1FDPS | |
| SCHEMBL9660538 | 0.98 | SMPD1 (0.49) | SMPD1CYP3A4L3MBTL1GGPS1FDPS | |
| SCHEMBL27881568 | 0.93 | SMPD1 (0.46) | SMPD1CYP3A4L3MBTL1GGPS1FDPS | |
| SCHEMBL9330199 | 0.91 | CYP3A4 (0.44) | SMPD1CYP3A4L3MBTL1FDPS | |
| SCHEMBL9658981 | 0.90 | SMPD1 (0.41) | SMPD1CYP3A4L3MBTL1GGPS1FDPS | |
| SCHEMBL27508174 | 0.86 | CYP3A4 (0.41) | SMPD1CYP3A4L3MBTL1GGPS1FDPS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104661708-B | viscous hemostatic compositions and methods of treatment | 尤法玛私人有限公司 | 2018-04-17 | — | — | CN | disclosed |